CHUGAI SEJJAKU KK has a total of 48 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CHUGAI PHARMACEUTICAL CO LTD, ZAKRYTOE AKTSIONERNOE OBSHCHESTVO BIOKAD and BEIJING HANMI PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 48 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Fermentation | |
#9 | Climate change mitigation in goods production | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Igava Tomojuki | 11 |
#2 | Tsunoda Khirojuki | 9 |
#3 | Tatibana Tatsukhiko | 8 |
#4 | Siraiva Khirotake | 8 |
#5 | Maeda Atsukhiko | 5 |
#6 | Kodzima Tetsuo | 5 |
#7 | Kuramoti Taiti | 4 |
#8 | Isii Sinja | 4 |
#9 | Khiguti Josinobu | 4 |
#10 | Sakurai Mika | 4 |
Publication | Filing date | Title |
---|---|---|
RU2565809C2 | Pharmaceutical formulation containing advanced antibody molecules | |
RU2524152C2 | Medication for treatment of rheumatoid arthritis | |
RU2537245C2 | Diagnosing and treating malignant tumour with using anti-ereg antibody | |
RU2448109C2 | Pyrimidine derivative as pi3k inhibitor and use thereof | |
RU2413731C2 | Novel water-soluble prodrugs | |
RU2319482C2 | Method for identification of anti-tumor target enzymes | |
RU2323926C2 | Carbonylation method | |
RU2230738C9 | Derivatives of vitamin d, compounds pharmaceutical composition, therapeutic agent, treatment method | |
RU2212413C2 | Monoclonal antibody prepared using integrin-associated protein, its fragment fab, fab' or f(ab')2, hybridoma producing monoclonal antibody (variant), antileukemic agent |